Lactoferrin: Potential to prevent COVID-19

Lactoferrin is a protein found in milk and other bodily fluids that has been shown to have antiviral and anti-inflammatory properties. Recent studies have found that lactoferrin can inhibit the replication of SARS-CoV-2, the virus that causes COVID-19, and may also modulate the immune response to the virus. Lactoferrin's antibacterial properties also help to reduce the risk of secondary infections. Additionally, lactoferrin has been found to reduce the risk of respiratory infections and improve lung function in individuals with chronic respiratory conditions such as asthma and COPD. While there is a body of preclinical and observational studies supporting the use of lactoferrin as a potential therapy for COVID-19. Several clinical trials evaluate the safety and efficacy of lactoferrin as a treatment for COVID-19. Overall, lactoferrin may hold promise as a preventative measure for COVID-19.